TRIB vs. MSFRX

In the year-to-date period, TRIB achieves a -39.39% return, which is significantly lower than MSFRX's 11.39% return. Over the past 10 years, TRIB has underperformed MSFRX with an annualized return of -34.09%, while MSFRX has yielded a comparatively higher 3.49% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Trinity Biotech plc (TRIB) and MFS Total Return Fund (MSFRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current TRIB Sharpe Ratio is -0.33, which is lower than the MSFRX Sharpe Ratio of 1.77. The chart below compares the historical Sharpe Ratios of TRIB and MSFRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

TRIB has not paid dividends to shareholders, while MSFRX's dividend yield for the trailing twelve months is around 2.22%.

The maximum TRIB drawdown since its inception was -99.25%, which is greater than MSFRX's maximum drawdown of -36.74%. Use the drawdown chart below to compare losses from any high point for TRIB and MSFRX. For additional features, visit the drawdowns tool.

Trinity Biotech plc (TRIB) has a higher volatility of 29.24% compared to MFS Total Return Fund (MSFRX) at 2.06%. This indicates that TRIB's price experiences larger fluctuations and is considered to be riskier than MSFRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.